EFTA02088726.pdf

To: From: Sent Mon 12/8/2014 1:06:29 PM Subject: Re: Confidential morning James...I don't think Jeffrey will be back in NY this month but one never knows! Let me give him your new dates... On Dec 8, 2014, at 7:26 AM, James Meiskin wrote: Anytime between the 15th — 17th of this month would be great. Thank you, James From: Sent: Wednesday, December 03, 2014 7:39 AM To: Subject: Re: Confidential I will see what I can do James. Thanks, Sent from my iPhone On Dec 2, 2014, at 11:19 PM, "James Meiskin" wrote: December 17th — 19th would be best if you can make it happen. Please let me know shortly. Thank you again for your help Best, James From: Sent: Monday, December 01, 2014 7:24 PM To: Subje : e: on en is Sure! Sent from my iPhone On Dec 1, 2014, at 7:21 PM, "James Meisldn" wrote: Can you please check to see if next week works for JE? Thank you. James From: Sent: Monday, November 03, 2014 11:42 AM To: James Meiskin Subject: Re: Confidential ok, thanks EFTA_R1_00682367 EFTA02088726  On Nov 3 2014 at 11:05 AM James Meiskin wrote: Thank you very much! I truly think that JE will enjoy meeting David, and he should also know that David is a substantive businessperson, who could also potentially get involved with opportunities/investments on his end as well. james From: Sent: Monday, November 03, 2014 9:38 AM To: Subject: Re: Confidential Hi James...unfortunately I have not heard back from Jeffrey on this...but let me try again!! :) On Nov 3, 2014, at 8:05 AM, James Meiskin wrotc: Hi Any word on when Jeffrey may have a brief window of time to meet with David Carter and myself, this week or next? David will also be meeting with the President of UBS when he is in NY, but is holding off on setting up that meeting until he gets a time from Jeffrey, so he can coordinate properly both meetings, and also make sure to see JE who he is excited to meet. Best, J From Sent: Wednesday, October 29, 2014 9:39 AM To: Subj : e: or enba Great! thanks James...I will pass this alon and hopefully Jeffrey will be available. Thank you, On Oct 29, 2014, at 8:15 AM, James Meiskin wrote: EFTA_R1_00682368 EFTA02088727  I attached the updated deck for JE's review. David Carter would like to meet Jeffrey over the next several weeks if possible, and I think that they would have much in common on many levels, and that Jeffrey would find the meeting to be worthwhile. Please let me know. Thank you. James Dear James, Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their country. For their investment they get commercialization rights to the technologies they finance for Russia and the CIS. For us, on the USA side, this is a major source of capital to start a series of companies that have great potential as therapeutic technologies, and we get commercialization rights for the USA, and rest of the world markets. Basically, we get the rights that are valuable to us at "half price". Over the next several years our plan is to identify seven/eight technologies that are worthy of development. RVC has already agreed to finance the first (MAJI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capital that thinks this is an interesting investment theme, and is willing to consider the idea as something they might want to implement. My belief is that there is more money in NYC, seeking an investment home, then there are "quality investment ideas". I could be wrong, but I have to believe that people running a lot of capital in New York would want to hear new, creative, and GOOD new investment ideas. I think this idea is the kind of idea that is worth a look, and worth serious consideration. I think we are talking $150M over a five year horizon. EFTA_R1_00682369 EFTA02088728  Best, David David W. Carter President—DaCart Capital LLC <DaCart Presentation Jul 7 2014.pdf> No virus found in this message. Checked by AVG - www.ave.com Version: 2015.0.5557 / Virus Database: 4189/8501 - Release Date: 11/03/14 EFTA_R1_00682370 EFTA02088729